Genta Kyushu Bio: Funding, Investors & Team (Sep 2026)
Genta Kyushu Bio develops precision neuro circuit therapies for CNS and eye diseases via optogenetics and chemogenetics.
Genta Kyushu Bio has raised $14.8M across 1 funding round on record, the most recent a Series A of $14.8M announced in Jul 2026.
That round is in line with the $15M median round size for China companies tracked on FundedIQ over the last two years.
Genta Kyushu Bio Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Genta Kyushu Bio Funding Rounds
Genta Kyushu Bio Investors
8 investors are recorded in total; the 5 named above are those the record identifies.
Genta Kyushu Bio Funding in Context
Genta Kyushu Bio's latest round of $14.8M is in line with the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genta Kyushu Bio in Biotechnology and Beijing
Companies Similar to Genta Kyushu Bio
Caspian Therapeutics is a biotechnology company developing menin inhibitors to treat diabetes.
Xuntu Technology is a data intelligence provider focused on investment research and decision-making.
Dyu Intelligent Mobility Technology Company is a major player in the e-bike business.
INMO Glass are Foldable, monocular Augmented Reality (AR) glasses.
Micronano Core is a researcher and developer of AIoT series chip products for intelligent IoT and advanced…
LLVision focuses on AR+AI technology integration and provides related hardware products and software services.
Inno Medicine specializes in research on the pathogenesis of atherosclerosis.
Zhuoyu Electric is dedicated to the research and development and manufacturing of core components for…
Raysolve is a semiconductor company focused on the design, R&D, and manufacture of unparalleled micro-LED…
Global leader in scenario logistics autonomous driving ?????????????
Zongwei Automation is a research and development enterprise focusing on automation flexibility technology and…
Rittal Medical has been cultivating the pet medical equipment market for many years, with a complete pre- and…
Genta Kyushu Bio Funding FAQs
What does Genta Kyushu Bio do?
Genta Kyushu Bio develops precision neuro circuit therapies for CNS and eye diseases via optogenetics and chemogenetics.
How much funding has Genta Kyushu Bio raised?
Genta Kyushu Bio has raised $14.8M across 1 round on record. The most recent is a Series A of $14.8M announced in Jul 2026.
When did Genta Kyushu Bio last raise funding?
Genta Kyushu Bio's most recent funding round on record is a Series A of $14.8M, announced in Jul 2026.
Who has invested in Genta Kyushu Bio?
Investors on record for Genta Kyushu Bio include Boto Bio Brain-Machine Fund, Gaorong Capital, Fortune Venture Capital, CITIC Capital Holdings, Huatai Zijin Investment. FundedIQ records 8 investors in total.
Where is Genta Kyushu Bio headquartered?
Genta Kyushu Bio is based in Beijing, China.
When was Genta Kyushu Bio founded?
Genta Kyushu Bio was founded in 2022.
About FundedIQ's Genta Kyushu Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genta Kyushu Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.